Literature DB >> 22242068

Toxic megacolon from hypervirulent Clostridium difficile infection (ribotype 027) following elective total knee replacement: an emerging challenge in modern health care.

Buchi Rajendra Babu Arumilli1, Prasanthi Koneru, Irfan Fayyaz.   

Abstract

We present a rare case of community acquired (presenting in hospital on the day of admission or within 48 h of admission) Clostridium difficile infection (CDI) with the hypervirulent (ribotype 027) strain causing toxic megacolon in a patient, diagnosed on the third postoperative day following an elective total knee replacement. The patient did not have any of the commonly reported risk factors for CDI. The source of sepsis was initially presumed to be the operated prosthetic joint, and this caused a delay in the correct diagnosis and institution of appropriate antimicrobial treatment which may have contributed to a poorer outcome. This case highlights the risk of patients arriving from the community manifesting life threatening CDI in the hospital.

Entities:  

Year:  2010        PMID: 22242068      PMCID: PMC3029095          DOI: 10.1136/bcr.06.2009.2017

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

Review 1.  New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.

Authors:  Herbert L DuPont; Kevin Garey; Juan-Pablo Caeiro; Zhi-Dong Jiang
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

2.  Pseudomembranous colitis associated with antibiotic prophylaxis in orthopaedic surgery.

Authors:  S R Cannon; P H Dyson; P J Sanderson
Journal:  J Bone Joint Surg Br       Date:  1988-08

3.  Clostridium difficile infection in orthopaedic patients.

Authors:  H J Clarke; R H Jinnah; R P Byank; Q G Cox
Journal:  J Bone Joint Surg Am       Date:  1990-08       Impact factor: 5.284

Review 4.  Hypervirulent strains of Clostridium difficile.

Authors:  Barry Cookson
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

5.  Long-term follow-up of patients with fulminant Clostridium difficile colitis.

Authors:  Aaron T Miller; Parissa Tabrizian; Alexander J Greenstein; Andrew Dikman; John Byrn; Celia Divino
Journal:  J Gastrointest Surg       Date:  2009-02-18       Impact factor: 3.452

6.  The burden of Clostridium difficile in surgical patients in the United States.

Authors:  Marc Zerey; B Lauren Paton; Amy E Lincourt; Keith S Gersin; Kent W Kercher; B Todd Heniford
Journal:  Surg Infect (Larchmt)       Date:  2007-12       Impact factor: 2.150

7.  Aetiology and surgical management of toxic megacolon.

Authors:  C Ausch; R D Madoff; M Gnant; H R Rosen; J Garcia-Aguilar; N Hölbling; F Herbst; V Buxhofer; B Holzer; D A Rothenberger; R Schiessel
Journal:  Colorectal Dis       Date:  2006-03       Impact factor: 3.788

Review 8.  Pathogenesis of Clostridium difficile infection.

Authors:  S P Borriello
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

9.  Antibiotic-associated diarrhoea and Clostridium difficile in the community.

Authors:  L Beaugerie; A Flahault; F Barbut; P Atlan; V Lalande; P Cousin; M Cadilhac; J-C Petit
Journal:  Aliment Pharmacol Ther       Date:  2003-04-01       Impact factor: 8.171

10.  Clostridium difficile ribotype 027, toxinotype III, the Netherlands.

Authors:  Ed J Kuijper; Renate J van den Berg; Sylvia Debast; Caroline E Visser; Dick Veenendaal; Annet Troelstra; Tjallie van der Kooi; Susan van den Hof; Daan W Notermans
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

View more
  1 in total

1.  Toxic megacolon from fulminant Clostridium difficile infection induced by topical silver sulphadiazine.

Authors:  Christopher B Tan; Dhyan Rajan; Mitanshu Shah; Shadab Ahmed; Lester Freedman; Kaleem Rizvon; Paul Mustacchia
Journal:  BMJ Case Rep       Date:  2012-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.